CKD alters the gut microbiome, and changes within the gut may, in turn, contribute to complications associated with CKD.² For ...

FDA approves Sunharbo (asundexian) with antiplatelet therapy to reduce ischemic stroke risk in adults with recent noncardioembolic stroke or high-risk TIA.

An international survey evaluated the global availability and national health system reimbursement of 20 innovative systemic therapies for renal cell carcinoma across diverse economic settings.

LUGPA 2026 hosted a healthcare “Conversation Across the Aisle” featuring Republican Chris Christie and Democrat David Axelrod ...

Artificial intelligence is changing the healthcare landscape across medicine disciplines. A LUGPA panel discussed how AI is ...

This is the first completed phase trial of neoadjuvant SABR before nephrectomy and IVC thrombectomy for renal cell carcinoma ...

Dr Ruchika Talwar was a keynote speaker at the LUGPA 2026 annual meeting in a session titled “The Future-Ready Urologist.” ...